Product Code: ETC6185224 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The overall migraine treatment market in Australia is expanding as healthcare providers adopt integrated approaches involving medication, behavioral therapy, and lifestyle modifications. Hospitals, neurologists, and primary care clinics are increasingly focusing on early diagnosis and effective treatment regimens. Increased patient education, coupled with digital consultation services, has made migraine treatment more accessible across urban and regional areas.
Australias migraine treatment landscape is diversifying, with improved access to preventive medications, digital headache trackers, and non-pharmacological therapies such as neuromodulation devices. Public and private healthcare initiatives are promoting early diagnosis and lifestyle-based interventions, contributing to market expansion.
Challenges in the migraine treatment market include a fragmented treatment landscape where patients often resort to trial-and-error approaches to find relief. This leads to dissatisfaction and inconsistent treatment outcomes. The healthcare system faces difficulties in standardizing migraine care protocols across public and private sectors. Access to neurologists and specialized care in remote regions remains limited. Moreover, the stigma associated with chronic migraines continues to affect treatment-seeking behavior, reducing early intervention rates.
The migraine treatment ecosystem in Australia offers investment potential in digital health apps for migraine management, tele-neurology platforms, and integrated headache clinics. Private equity and health-tech investors are particularly interested in scalable models that combine treatment, data analytics, and preventive care.
Government policies in Australia regarding migraine treatment are primarily concerned with the accessibility and affordability of treatments. The PBS ensures that some migraine medications are subsidized, but newer or more specialized treatments still face high out-of-pocket costs for patients. Policies promoting public health awareness about the prevalence of migraines and the availability of treatments are beginning to take hold. However, limited funding for chronic disease management programs that focus on migraine still impacts overall access to comprehensive treatment options. There is also a need for greater integration of migraine management into primary healthcare protocols.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Migraine Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Migraine Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Migraine Treatment Market - Industry Life Cycle |
3.4 Australia Migraine Treatment Market - Porter's Five Forces |
3.5 Australia Migraine Treatment Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Australia Migraine Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Australia Migraine Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Migraine Treatment Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Australia Migraine Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Migraine Treatment Market Trends |
6 Australia Migraine Treatment Market, By Types |
6.1 Australia Migraine Treatment Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Australia Migraine Treatment Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Australia Migraine Treatment Market Revenues & Volume, By Episodic, 2021- 2031F |
6.1.4 Australia Migraine Treatment Market Revenues & Volume, By Migraine with Aura, 2021- 2031F |
6.1.5 Australia Migraine Treatment Market Revenues & Volume, By Chronic, 2021- 2031F |
6.1.6 Australia Migraine Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Migraine Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Australia Migraine Treatment Market Revenues & Volume, By Acute/Abortive Treatment, 2021- 2031F |
6.2.3 Australia Migraine Treatment Market Revenues & Volume, By Preventive/prophylactic Treatment, 2021- 2031F |
6.2.4 Australia Migraine Treatment Market Revenues & Volume, By Non-Pharmacological Therapies and Devices, 2021- 2031F |
6.3 Australia Migraine Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Migraine Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Migraine Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Australia Migraine Treatment Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Australia Migraine Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Migraine Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Australia Migraine Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Australia Migraine Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Migraine Treatment Market Import-Export Trade Statistics |
7.1 Australia Migraine Treatment Market Export to Major Countries |
7.2 Australia Migraine Treatment Market Imports from Major Countries |
8 Australia Migraine Treatment Market Key Performance Indicators |
9 Australia Migraine Treatment Market - Opportunity Assessment |
9.1 Australia Migraine Treatment Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Australia Migraine Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Australia Migraine Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Migraine Treatment Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Australia Migraine Treatment Market - Competitive Landscape |
10.1 Australia Migraine Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Migraine Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |